Blood Pressure
Cleviprex(TM) Demonstrated Rapid, Precise Blood Pressure Control in High-Risk Patients, According to New Analyses
Published in Blood Weekly, February 21st, 2008
The Medicines Company (NASDAQ: MDCO) announced that its investigational agent, Cleviprex(TM) (clevidipine butyrate injectable emulsion), rapidly achieved and maintained blood pressure control in patients with renal dysfunction (RD) and patients with acute heart failure (AHF), according to two new analyses from the Phase III trial VELOCITY(1) presented at the annual meeting of the Society of Clinical Care Medicine (SCCM).
Target blood pressure control was achieved with Cleviprex, administered by intravenous (IV) infusion, by a median of 6.3 minutes for patients with RD and 11.3 minutes for patients with AHF, with 91 percent of RD patients (N=24) and 94 percent of AHF...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-02-21)
More Articles from Blood Weekly
- Heart Attack
Novel compound may lessen heart attack damage - Acute Pancreatitis
Study findings from University College broaden understanding of acute pancreatitis - Acute Promyelocytic Leukemia
Cleveland Clinic details research in acute promyelocytic leukemia - Autoimmune Hemolytic Anemia
New autoimmune hemolytic anemia research from University of Patras, Medical Department described - Biomedicine
BioWizard Offers Conference Abstracts with the Launch of myBW - Clinical and Laboratory Standards Institute
CLSI Publishes Protocol for the Evaluation, Validation, and Implementation of Coagulometers - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
